Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers Meeting Abstract


Authors: Diaz, L.; Marabelle, A.; Kim, T. W.; Geva, R.; Van Cutsem, E.; André, T.; Ascierto, P. A.; Maio, M.; Delord, J. P.; Gottfried, M.; Guimbaud, R.; Jaeger, D.; Elez, E.; Yoshino, T.; Joe, A.; Lam, B.; Ding, J.; Pruitt, S.; Kang, S. P.; Le, D. T.
Abstract Title: Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers
Meeting Title: 42nd ESMO Congress (ESMO 2017)
Journal Title: Annals of Oncology
Volume: 28
Issue: Suppl. 5
Meeting Dates: 2017 Sep 8-12
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2017-09-01
Start Page: mdx367.020
Language: English
ACCESSION: WOS:000411324001046
PROVIDER: wos
DOI: 10.1093/annonc/mdx367.020
Notes: Meeting Abstract: 386P -- Appears on pages 128-129 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Luis Alberto Diaz
    148 Diaz